FNBT
MDCO

FineMark National Bank & Trust’s Medicines Co MDCO Stock Holding History

FineMark National Bank & Trust’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300
Closed -$8K – 1482
2014
Q4 		$8K Hold
300
– – ﹤0.01% 1076
2014
Q3 		$7K Hold
300
– – ﹤0.01% 1085
2014
Q2 		$9K Hold
300
– – ﹤0.01% 1064
2014
Q1 		$9K Buy
+300
New +$9.93K ﹤0.01% 1078

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

FineMark National Bank & Trust's MDCO Position: Q1 2015 in Review

FineMark National Bank & Trust sold out of Medicines Co (MDCO) in Q1 2015, closing a stake of 300 shares — an estimated $8K sold.

FineMark National Bank & Trust first reported a position in MDCO in Q1 2014 and held it in 4 quarters. The position peaked at $9K in Q2 2014. 184 funds tracked by Wall St. Rank hold MDCO as of Q1 2015.

  • FineMark National Bank & Trust reported no remaining Medicines Co position as of Q1 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 300 Medicines Co shares in Q1 2015, an estimated $8K.
  • FineMark National Bank & Trust first reported a position in Medicines Co in Q1 2014 and held it in 4 quarters.
  • FineMark National Bank & Trust's Medicines Co position peaked at $9K in Q2 2014.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q1 2015.

Based on FineMark National Bank & Trust's 13F filing for Q1 2015, filed 13 May 2015.